
The Clorox Company (NYSE:CLX – Free Report) – Equities researchers at Zacks Research lowered their Q2 2027 earnings per share (EPS) estimates for shares of Clorox in a research report issued on Monday, November 16th. Zacks Research analyst Team now anticipates that the company will earn $1.02 per share for the quarter, down from their prior forecast of $1.30. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.74 per share. Zacks Research also issued estimates for Clorox’s FY2027 earnings at $5.71 EPS and FY2029 earnings at $6.20 EPS.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.48. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The company had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.88 billion. During the same period in the prior year, the company posted $0.85 EPS. The firm’s quarterly revenue was up 33.3% compared to the same quarter last year.
A number of other equities research analysts have also weighed in on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $83.00 to $86.00 and gave the company an “underweight” rating in a report on Tuesday, November 3rd. Wells Fargo & Company raised their target price on Clorox from $85.00 to $90.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 6th. UBS Group set a $88.00 price target on Clorox in a research note on Tuesday, November 3rd. Finally, Evercore raised Clorox from an “underperform” rating to a “hold” rating and set a $99.00 price objective on the stock in a report on Monday, November 2nd. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $93.79.
Read Our Latest Report on Clorox
Clorox Price Performance
Shares of CLX stock opened at $106.62 on Wednesday. Clorox has a fifty-two week low of $79.12 and a fifty-two week high of $128.90. The company has a debt-to-equity ratio of 32.91, a quick ratio of 0.39 and a current ratio of 0.65. The firm has a market capitalization of $12.92 billion, a price-to-earnings ratio of 19.18, a PEG ratio of 3.49 and a beta of 0.59. The stock’s 50-day simple moving average is $89.39 and its 200-day simple moving average is $99.53.
Hedge Funds Weigh In On Clorox
Several institutional investors and hedge funds have recently modified their holdings of CLX. NewEdge Advisors LLC increased its holdings in shares of Clorox by 11.8% in the 2nd quarter. NewEdge Advisors LLC now owns 75,135 shares of the company’s stock valued at $7,171,000 after acquiring an additional 7,956 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in shares of Clorox during the 2nd quarter worth about $3,277,000. Corient Private Wealth LP purchased a new stake in Clorox during the second quarter worth approximately $6,621,000. Allen Mooney & Barnes Investment Advisors LLC lifted its stake in Clorox by 3,309.3% during the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 186,316 shares of the company’s stock worth $15,093,000 after purchasing an additional 180,851 shares during the last quarter. Finally, Equity Investment Corp lifted its stake in Clorox by 34.8% during the third quarter. Equity Investment Corp now owns 1,578,983 shares of the company’s stock worth $127,913,000 after purchasing an additional 407,569 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Insider Activity
In other Clorox news, Director Pierre Breber bought 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 4th. The stock was bought at an average cost of $100.06 per share, for a total transaction of $400,240.00. Following the completion of the transaction, the director directly owned 22,000 shares of the company’s stock, valued at approximately $2,201,320. This trade represents a 22.22% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.51% of the stock is currently owned by company insiders.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 12th. Investors of record on Wednesday, January 27th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend is Wednesday, January 27th. Clorox’s dividend payout ratio (DPR) is 89.93%.
Trending Headlines about Clorox
These are some of the CLX headlines that stood out recently:
- Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $5.71 from $5.53, and its Q1 FY2028 estimate to $1.29 from $1.10. These increases offer a limited counterpoint to the broader reductions.
- Neutral Sentiment: Clorox declared its regular quarterly dividend of $1.25 per share, equivalent to $5.00 annually and a reported yield of 4.7%. The payout may appeal to income-focused investors, but no increase was announced. Clorox Declares Regular Quarterly Dividend of $1.25 Per Share
- Negative Sentiment: Zacks Research lowered its Q2 FY2027 EPS estimate to $1.02 from $1.30 and its FY2029 estimate to $6.20 from $6.89. It also cut its FY2028 forecast to $6.01 from $6.23 and reduced several quarterly projections. The breadth of the cuts, alongside its “Strong Sell” rating, is the clearest negative catalyst in the news.
About Clorox
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Read More
- Five stocks we like better than Clorox
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
